davunetide [Supplementary Concept]
AL-108 is a nasal systemic formulation; AL-208 is an intravenous formulation; associated with glial proteins regulated by vasoactive intestinal peptide, are shown now to provide protective intervention in a model of fetal alcohol syndrome
Date introduced: May 17, 2001
MeSH Unique ID: C425904
Registry Number: GF00K3IIWE
Heading Mapped to:
Entry Terms:
- NAPVSIPQ peptide
- NAP peptide
- D-NAP peptide
- AL-408
- AL 108
- AL108 cpd
- AL-108
- AL 208
- AL208 cpd
- AL-208